Samantha T. Reyes

Visualizing Nerve Injury in a Neuropathic Pain Model with [F]FTC-146 PET/MRI.

GABA Measurement in a Neonatal Fragile X Syndrome Mouse Model Using H-Magnetic Resonance Spectroscopy and Mass Spectrometry.

Evaluation of carbon-11 labeled 5-(1-methyl-1H-pyrazol-4-yl)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)nicotinamide as PET tracer for imaging of CSF-1R expression in the brain.

BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain.

Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy.

A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2-Induced Glycolytic Reprogramming in Glioblastoma.

Brain cell signaling abnormalities are detected in blood in a murine model of Fragile X syndrome and corrected by Sigma-1 receptor agonist Blarcamesine.

Radiosynthesis and initial preclinical evaluation of [C]AZD1283 as a potential P2Y12R PET radiotracer.

Multimodal imaging of capsid and cargo reveals differential brain targeting and liver detargeting of systemically-administered AAVs.

Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain.